Cipla gets US FDA approval for Lopinavir and ritonavir oral pellets
These are used for the treatment of AIDS in infants and young children
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Subhanu Saxena
Cipla, Serum Institute agreement
Signs exclusive distribution agreement for flu vaccine ‘Nasovac-S’ for India Cipla has signed an agreement with Serum Institute…
Cipla launches generic drug Sofosbuvir in India
The drug will be sold under the brand name ‘Hepcvir'
Cipla wins US$ 188.95 million of Global Fund ARV tender
The anti-retrovirals drugs will be manufactured in Cipla’s state-of-the-art manufacturing facilities in India, which has been…
Cipla’s UK arm in JV with Cooper Pharma and PHI
The agreement facilitates Cipla with a front-end presence in Morocco and enables it to develop a platform for the future with…
Cipla bags Rs 1,100 cr order for HIV drugs from South Africa
The medication will be produced at the company's 23,000 square meter manufacturing site in Kwazulu-Natal
Medicines for Malaria Venture announces collaborations with Cipla and Strides
Collaborations set to advance life-saving pre-referral treatment for severe malaria